47 –50
Antibiotic prophylaxis in vesicoureteric reflux in children.
Authors: Dr Asma Aref Idamat, Dr Najeh Yousef Alomari
Number of views: 472
Urinary tract infection (UTI) is known entity and a common problem in pediatric age group. Children at risk for (UTI) such as vesicoureteric reflux (VUR), pelvi-ureteric junction obstruction (PUJO) and other urinary tract anomalies commonly receive prophylactic antibiotics to prevent nephropathy such as renal scaring ,hypertension and renal failure. Prolonged use of prophylactic antibiotics is common for recurrent (UTI), but this has not been assessed in well-controlled prospective studies. Different antibiotics such as nitrofurantoin, trimethoprim/sulfamethoxazole and nalidixcic acid have been used as prophylactic antibiotics to prevent (UTI) in pediatric age group which proved to be safe in long term prophylactic therapy without major complications. Although it is not easy to perform prospective studies in children because both clinical course and prognosis may be affected by many factors. Infant and children with factors need prolonged use of antibiotic prophylaxis, until there is evidence that these patients are not at risk without prophylaxis. We reviewed thoroughly the up to date literatures and practice guidelines to make sure that we are implementing appropriate use of antibiotic prophylaxis in pediatric urology in our institution being the referral pediatric hospital dealing with the vast majority of pediatric urology/ nephrology cases in the kingdom. We focus on the evaluation and actual benefits of prophylactic antibiotics in vesicoureteric reflux (VUR) in pediatric age group to reach consensus and recommendations for in hospital protocol on the basis of current best evidence. Over the past 3 years we selected a group of patients (N=130), 50 males and 80 females , age 4-7 years ,median age 5, 2 years with grad I-III (VUR).All patients with abnormal voiding , neurogenic bladder and urinary tract anomalies were excluded from the study. All patients who had breakthrough (UTI) or deterioration in the renal function were excluded from the study and managed by surgery or endoscopic injection. All patients were treated by prophylactic antibiotics for 18 months (first trial) then stopped and followed up for another 18 months on no prophylaxis (second trial). At the end of both trials, 100 patients met the inclusion criteria and the results were analyzed. There was no significant break though infection in the second trial and no significant drop in the renal function. Multi resistant bacterial growth was encounter in the first trial, while less resistant bacterial growth was encountered in the second trial. In conclusion, routine use of prophylactic antibiotics for low grade I-III (VUR) in normal urinary tract is not indicated after the age of 4 years without any significant health compromise.